National Toxicology Program

National Toxicology Program
https://ntp.niehs.nih.gov/go/5302

TDMS Study 96007-03 Pathology Tables

NTP                                        STATISTICAL ANALYSIS OF PRIMARY TUMORS                              REPORT: PEIRPT08     
LAB: Battelle Columbus                         TOXIC EQUIVALENCY FACTOR EVALUATION (TCDD)                      DATE: 09/30/03       
EXPERIMENT: 96007 TEST: 03                                                                                     TIME: 08:52:44       
TEST TYPE:  CHRONIC                             CAGES FROM 0000 TO LAST CAGE                                   PAGE:       1        
CONT: NO1-ES-75411                              ROUTE: GAVAGE                                                  NTP C#: 96007G       
PATHOLOGIST: SELLS, DONALD                                                                                     CAS: 1746-01-6       
------------------------------------------------------------------------------------------------------------------------------------
                                                                                                                                    
                                                 FINAL # 3 RATS CONTROL VS TREATED                                                  
                                                                                                                                    
                                                                                                                                    
               REASONS FOR REMOVAL:    25018 Dosing Accident                                                                        
                                       25019 Moribund Sacrifice                                                                     
                                       25020 Natural Death                                                                          
                                       25021 Terminal Sacrifice                                                                     
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
               REMOVAL DATE RANGE:     ALL                                                                                          
                                                                                                                                    
               TREATMENT GROUPS:       INCLUDE 001    0 NG/KG                                                                       
                                       INCLUDE 002    3 NG/KG                                                                       
                                       INCLUDE 003    10 NG/KG                                                                      
                                       INCLUDE 004    22 NG/KG                                                                      
                                       INCLUDE 005    46 NG/KG                                                                      
                                       INCLUDE 006    100     NG/KG                                                                 
                                                                                                                                   
NTP                                        STATISTICAL ANALYSIS OF PRIMARY TUMORS                              REPORT: PEIRPT08     
LAB: Battelle Columbus                         TOXIC EQUIVALENCY FACTOR EVALUATION (TCDD)                      DATE: 09/30/03       
EXPERIMENT: 96007 TEST: 03                                                                                     TIME: 08:52:44       
TEST TYPE:  CHRONIC                             CAGES FROM 0000 TO LAST CAGE                                                        
CONT: NO1-ES-75411                              ROUTE: GAVAGE                                                  NTP C#: 96007G       
PATHOLOGIST: SELLS, DONALD                                                                                     CAS: 1746-01-6       
Rats(SPRAGUE-DAWLEY)                                                                                                                
-----------------------------                                                                                                       
FOR ALL DOSES THE TUMOR RATES IN THE FOLLOWING TISSUES/ORGANS ARE                                                                   
BASED ON NUMBER OF TISSUES EXAMINED.  IN OTHER TISSUES/ORGANS RATES                                                                 
ARE BASED ON THE NUMBER OF ANIMALS NECROPSIED.                                                                                      
                                                 ---------------                                                                    
                                                 Adrenal Cortex                                                                     
                                                 Adrenal Medulla                                                                    
                                                 Brain                                                                              
                                                 Heart                                                                              
                                                 Islets, Pancreatic                                                                 
                                                 Kidney                                                                             
                                                 Liver                                                                              
                                                 Lung                                                                               
                                                 Ovary                                                                              
                                                 Pancreas                                                                           
                                                 Parathyroid Gland                                                                  
                                                 Pituitary Gland                                                                    
                                                 Spleen                                                                             
                                                 Thyroid Gland                                                                      
                                                 Urinary Bladder                                                                    
                                                                                                                                   
NTP                                        STATISTICAL ANALYSIS OF PRIMARY TUMORS                              REPORT: PEIRPT08     
LAB: Battelle Columbus                         TOXIC EQUIVALENCY FACTOR EVALUATION (TCDD)                      DATE: 09/30/03       
EXPERIMENT: 96007 TEST: 03                                                                                     TIME: 08:52:44       
TEST TYPE:  CHRONIC                             CAGES FROM 0000 TO LAST CAGE                                                        
CONT: NO1-ES-75411                              ROUTE: GAVAGE                                                  NTP C#: 96007G       
PATHOLOGIST: SELLS, DONALD                                                                                     CAS: 1746-01-6       
                                                                                                                                    
                                                                                                                                    
SUMMARY OF STATISTICALLY SIGNIFICANT (P<=.05) RESULTS                                                                               
IN THE ANALYSIS OF       TOXIC EQUIVALENCY FACTOR EVALUATION                                                                        
===============================================================                                                                     
Female Rats                                                                                                                         
------------                                                                                                                        
Organ                                  Morphology                                                                                   
-----                                  ----------                                                                                   
Liver                                  Cholangiocarcinoma                                                                           
                                       Hepatocellular Adenoma                                                                       
                                       Hepatocholangioma                                                                            
Lung                                   Cystic Keratinizing Epithelioma                                                              
Mammary Gland                          Carcinoma                                                                                    
                                       Carcinoma or Adenoma                                                                         
                                       Fibroadenoma                                                                                 
                                       Fibroma, Fibroadenoma or Adenoma                                                             
                                       Fibroma, Fibroadenoma, Carcinoma, or Adenoma                                                 
Oral Cavity (Oral Mucosa, Tongue, Pharynx, Tooth, Gingiva)                                                                          
                                       Squamous Cell Carcinoma                                                                      
                                       Squamous Cell Carcinoma, Papilloma Squamous, or Papilloma                                    
Oral Mucosa                            Squamous Cell Carcinoma                                                                      
Pancreas                               Carcinoma                                                                                    
                                       Carcinoma or Adenoma                                                                         
Pituitary Gland: Pars Distalis or Unspecified Site                                                                                  
                                       Adenoma                                                                                      
Pituitary Gland: Pars Intermedia       Adenoma                                                                                      
Thyroid Gland: C-Cell                  Adenoma                                                                                      
                                       Carcinoma or Adenoma                                                                         
Uterus                                 Polyp Stromal                                                                                
                                       Squamous Cell Carcinoma                                                                      
All Organs                             Benign Tumors                                                                                
                                       Malignant Tumors                                                                             
                                       Malignant and Benign Tumors                                                                  
===============================================================                                                                     
                                                                                                                                   
       Date:  09/30/03                           EXPERIMENT: 96007 TEST: 03                                            Page 1       
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY)        -        TOXIC EQUIVALENCY FACTOR EVALUATION                  
                                         Terminal Sacrifice at 105 weeks                                                            
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Adrenal Cortex                                                                                                                   | 
|     Adenoma                                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        1/53 (2%)        0/54 (0%)        2/53 (4%)        2/53 (4%)        1/53 (2%)        1/53 (2%)       | 
|POLY-3 RATE (b)    |        1/39.55          0/34.61          2/38.75          2/34.53          1/39.00          1/42.90         | 
|POLY-3 PERCENT (g) |        2.5%             0.0%             5.2%             5.8%             2.6%             2.3%            | 
|TERMINAL (d)       |        1/25 (4%)        0/21 (0%)        2/23 (9%)        1/19 (5%)        1/22 (5%)        0/21 (0%)       | 
|FIRST INCIDENCE    |        731 (T)          ---              731 (T)          626              731 (T)          648             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.609N         P=0.535N         P=0.471          P=0.403          P=0.734          P=0.744         | 
|POLY 3             |        P=0.549N         P=0.527N         P=0.493          P=0.453          P=0.758          P=0.743N        | 
|POLY 1.5           |        P=0.567N         P=0.514N         P=0.490          P=0.472          P=0.759          P=0.745N        | 
|POLY 6             |        P=0.542N         P=0.539N         P=0.494          P=0.430          P=0.755          P=0.747N        | 
|LOGISTIC REGRESSION|        P=0.560N         (e)              P=0.471          P=0.433          P=0.734          P=0.749N        | 
|COCH-ARM / FISHERS |        P=0.614N         P=0.495N         P=0.500          P=0.500          P=0.752N         P=0.752N        | 
|ORDER RESTRICTED   |        P=0.450          (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Adrenal Medulla                                                                                                                  | 
|     Pheochromocytoma Benign                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        3/53 (6%)        2/54 (4%)        2/53 (4%)        3/53 (6%)        3/53 (6%)        3/53 (6%)       | 
|POLY-3 RATE (b)    |        3/39.55          2/34.61          2/38.75          3/34.16          3/39.09          3/43.18         | 
|POLY-3 PERCENT (g) |        7.6%             5.8%             5.2%             8.8%             7.7%             7.0%            | 
|TERMINAL (d)       |        3/25 (12%)       2/21 (10%)       2/23 (9%)        3/19 (16%)       2/22 (9%)        0/21 (0%)       | 
|FIRST INCIDENCE    |        731 (T)          731 (T)          731 (T)          731 (T)          708              642             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.414          P=0.581N         P=0.539N         P=0.532          P=0.604          P=0.606         | 
|POLY 3             |        P=0.542          P=0.561N         P=0.509N         P=0.594          P=0.658          P=0.622N        | 
|POLY 1.5           |        P=0.516          P=0.533N         P=0.512N         P=0.623          P=0.660          P=0.629N        | 
|POLY 6             |        P=0.550          P=0.590N         P=0.508N         P=0.557          P=0.653          P=0.628N        | 
|LOGISTIC REGRESSION|        P=0.492          P=0.581N         P=0.539N         P=0.532          P=0.618          P=0.642N        | 
|COCH-ARM / FISHERS |        P=0.436          P=0.491N         P=0.500N         P=0.661N         P=0.661N         P=0.661N        | 
|ORDER RESTRICTED   |        P=0.688          (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  09/30/03                           EXPERIMENT: 96007 TEST: 03                                            Page 2       
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY)       -        TOXIC EQUIVALENCY FACTOR EVALUATION                   
                                         Terminal Sacrifice at 105 weeks                                                            
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Adrenal Medulla                                                                                                                  | 
|     Pheochromocytoma: Benign, Complex, Malignant, NOS                                                                           | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        3/53 (6%)        2/54 (4%)        2/53 (4%)        3/53 (6%)        3/53 (6%)        3/53 (6%)       | 
|POLY-3 RATE (b)    |        3/39.55          2/34.61          2/38.75          3/34.16          3/39.09          3/43.18         | 
|POLY-3 PERCENT (g) |        7.6%             5.8%             5.2%             8.8%             7.7%             7.0%            | 
|TERMINAL (d)       |        3/25 (12%)       2/21 (10%)       2/23 (9%)        3/19 (16%)       2/22 (9%)        0/21 (0%)       | 
|FIRST INCIDENCE    |        731 (T)          731 (T)          731 (T)          731 (T)          708              642             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.414          P=0.581N         P=0.539N         P=0.532          P=0.604          P=0.606         | 
|POLY 3             |        P=0.542          P=0.561N         P=0.509N         P=0.594          P=0.658          P=0.622N        | 
|POLY 1.5           |        P=0.516          P=0.533N         P=0.512N         P=0.623          P=0.660          P=0.629N        | 
|POLY 6             |        P=0.550          P=0.590N         P=0.508N         P=0.557          P=0.653          P=0.628N        | 
|LOGISTIC REGRESSION|        P=0.492          P=0.581N         P=0.539N         P=0.532          P=0.618          P=0.642N        | 
|COCH-ARM / FISHERS |        P=0.436          P=0.491N         P=0.500N         P=0.661N         P=0.661N         P=0.661N        | 
|ORDER RESTRICTED   |        P=0.688          (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Islets, Pancreatic                                                                                                               | 
|     Adenoma                                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        1/51 (2%)        0/54 (0%)        2/53 (4%)        0/53 (0%)        0/52 (0%)        0/52 (0%)       | 
|POLY-3 RATE (b)    |        1/38.86          0/34.61          2/38.75          0/34.16          0/38.45          0/41.64         | 
|POLY-3 PERCENT (g) |        2.6%             0.0%             5.2%             0.0%             0.0%             0.0%            | 
|TERMINAL (d)       |        1/25 (4%)        0/21 (0%)        2/23 (9%)        0/19 (0%)        0/22 (0%)        0/21 (0%)       | 
|FIRST INCIDENCE    |        731 (T)          ---              731 (T)          ---              ---              ---             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.248N         P=0.535N         P=0.471          P=0.555N         P=0.525N         P=0.535N        | 
|POLY 3             |        P=0.205N         P=0.523N         P=0.499          P=0.526N         P=0.502N         P=0.486N        | 
|POLY 1.5           |        P=0.218N         P=0.509N         P=0.499          P=0.512N         P=0.500N         P=0.486N        | 
|POLY 6             |        P=0.196N         P=0.537N         P=0.497          P=0.542N         P=0.506N         P=0.493N        | 
|LOGISTIC REGRESSION|        P=0.248N         (e)              P=0.471          (e)              (e)              (e)             | 
|COCH-ARM / FISHERS |        P=0.236N         P=0.486N         P=0.515          P=0.490N         P=0.495N         P=0.495N        | 
|ORDER RESTRICTED   |        P=0.245N         (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  09/30/03                           EXPERIMENT: 96007 TEST: 03                                            Page 3       
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY)       -        TOXIC EQUIVALENCY FACTOR EVALUATION                   
                                         Terminal Sacrifice at 105 weeks                                                            
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Islets, Pancreatic                                                                                                               | 
|     Carcinoma or Adenoma                                                                                                        | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        2/51 (4%)        0/54 (0%)        2/53 (4%)        0/53 (0%)        0/52 (0%)        0/52 (0%)       | 
|POLY-3 RATE (b)    |        2/39.17          0/34.61          2/38.75          0/34.16          0/38.45          0/41.64         | 
|POLY-3 PERCENT (g) |        5.1%             0.0%             5.2%             0.0%             0.0%             0.0%            | 
|TERMINAL (d)       |        1/25 (4%)        0/21 (0%)        2/23 (9%)        0/19 (0%)        0/22 (0%)        0/21 (0%)       | 
|FIRST INCIDENCE    |        645              ---              731 (T)          ---              ---              ---             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.149N         P=0.302N         P=0.662          P=0.318N         P=0.260N         P=0.265N        | 
|POLY 3             |        P=0.115N         P=0.265N         P=0.691          P=0.268N         P=0.241N         P=0.223N        | 
|POLY 1.5           |        P=0.126N         P=0.248N         P=0.692          P=0.252N         P=0.238N         P=0.223N        | 
|POLY 6             |        P=0.107N         P=0.285N         P=0.687          P=0.291N         P=0.246N         P=0.232N        | 
|LOGISTIC REGRESSION|        P=0.133N         P=0.263N         P=0.693          P=0.267N         P=0.239N         P=0.224N        | 
|COCH-ARM / FISHERS |        P=0.144N         P=0.234N         P=0.676N         P=0.238N         P=0.243N         P=0.243N        | 
|ORDER RESTRICTED   |        P=0.053N         (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Kidney: Renal Tubule                                                                                                             | 
|     Nephroblastoma                                                                                                              | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/53 (0%)        2/54 (4%)        1/53 (2%)        0/53 (0%)        0/53 (0%)        0/53 (0%)       | 
|POLY-3 RATE (b)    |        0/39.55          2/36.54          1/39.71          0/34.16          0/39.00          0/42.60         | 
|POLY-3 PERCENT (g) |        0.0%             5.5%             2.5%             0.0%             0.0%             0.0%            | 
|TERMINAL (d)       |        0/25 (0%)        0/21 (0%)        0/23 (0%)        0/19 (0%)        0/22 (0%)        0/21 (0%)       | 
|FIRST INCIDENCE    |        ---              200              240              ---              ---              ---             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.212N         P=0.248          P=0.492          (e)              (e)              (e)             | 
|POLY 3             |        P=0.218N         P=0.219          P=0.501          (e)              (e)              (e)             | 
|POLY 1.5           |        P=0.215N         P=0.230          P=0.498          (e)              (e)              (e)             | 
|POLY 6             |        P=0.224N         P=0.208          P=0.502          (e)              (e)              (e)             | 
|LOGISTIC REGRESSION|        P=0.374N         P=0.189          P=0.663          (e)              (e)              (e)             | 
|COCH-ARM / FISHERS |        P=0.215N         P=0.252          P=0.500          (e)              (e)              (e)             | 
|ORDER RESTRICTED   |        P=0.243N         (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  09/30/03                           EXPERIMENT: 96007 TEST: 03                                            Page 4       
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY)       -        TOXIC EQUIVALENCY FACTOR EVALUATION                   
                                         Terminal Sacrifice at 105 weeks                                                            
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Liver                                                                                                                            | 
|     Cholangiocarcinoma                                                                                                          | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/53 (0%)        0/54 (0%)        0/53 (0%)        1/53 (2%)        4/53 (8%)        25/53 (47%)     | 
|POLY-3 RATE (b)    |        0/39.55          0/34.61          0/38.75          1/34.63          4/39.00          25/45.58        | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             2.9%             10.3%            54.9%           | 
|TERMINAL (d)       |        0/25 (0%)        0/21 (0%)        0/23 (0%)        0/19 (0%)        4/22 (18%)       13/21 (62%)     | 
|FIRST INCIDENCE    |        ---              ---              ---              592              731 (T)          610             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P<0.001 **       (e)              (e)              P=0.462          P=0.046 *        P<0.001 **      | 
|POLY 3             |        P<0.001 **       (e)              (e)              P=0.474          P=0.057          P<0.001 **      | 
|POLY 1.5           |        P<0.001 **       (e)              (e)              P=0.484          P=0.059          P<0.001 **      | 
|POLY 6             |        P<0.001 **       (e)              (e)              P=0.461          P=0.055          P<0.001 **      | 
|LOGISTIC REGRESSION|        P<0.001 **       (e)              (e)              P=0.508          P=0.046 *        P<0.001 **      | 
|COCH-ARM / FISHERS |        P<0.001 **       (e)              (e)              P=0.500          P=0.059          P<0.001 **      | 
|ORDER RESTRICTED   |        P<0.001 **       (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Liver                                                                                                                            | 
|     Hepatocellular Adenoma                                                                                                      | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/53 (0%)        0/54 (0%)        0/53 (0%)        0/53 (0%)        1/53 (2%)        13/53 (25%)     | 
|POLY-3 RATE (b)    |        0/39.55          0/34.61          0/38.75          0/34.16          1/39.04          13/43.52        | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             2.6%             29.9%           | 
|TERMINAL (d)       |        0/25 (0%)        0/21 (0%)        0/23 (0%)        0/19 (0%)        0/22 (0%)        7/21 (33%)      | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              720              642             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P<0.001 **       (e)              (e)              (e)              P=0.476          P<0.001 **      | 
|POLY 3             |        P<0.001 **       (e)              (e)              (e)              P=0.497          P<0.001 **      | 
|POLY 1.5           |        P<0.001 **       (e)              (e)              (e)              P=0.499          P<0.001 **      | 
|POLY 6             |        P<0.001 **       (e)              (e)              (e)              P=0.494          P<0.001 **      | 
|LOGISTIC REGRESSION|        P<0.001 **       (e)              (e)              (e)              P=0.487          P<0.001 **      | 
|COCH-ARM / FISHERS |        P<0.001 **       (e)              (e)              (e)              P=0.500          P<0.001 **      | 
|ORDER RESTRICTED   |        P<0.001 **       (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  09/30/03                           EXPERIMENT: 96007 TEST: 03                                            Page 5       
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY)       -        TOXIC EQUIVALENCY FACTOR EVALUATION                   
                                         Terminal Sacrifice at 105 weeks                                                            
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Liver                                                                                                                            | 
|     Hepatocholangioma                                                                                                           | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/53 (0%)        0/54 (0%)        0/53 (0%)        0/53 (0%)        0/53 (0%)        2/53 (4%)       | 
|POLY-3 RATE (b)    |        0/39.55          0/34.61          0/38.75          0/34.16          0/39.00          2/42.93         | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             0.0%             4.7%            | 
|TERMINAL (d)       |        0/25 (0%)        0/21 (0%)        0/23 (0%)        0/19 (0%)        0/22 (0%)        1/21 (5%)       | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              ---              638             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.015 *        (e)              (e)              (e)              (e)              P=0.229         | 
|POLY 3             |        P=0.012 *        (e)              (e)              (e)              (e)              P=0.256         | 
|POLY 1.5           |        P=0.012 *        (e)              (e)              (e)              (e)              P=0.253         | 
|POLY 6             |        P=0.012 *        (e)              (e)              (e)              (e)              P=0.251         | 
|LOGISTIC REGRESSION|        P=0.015 *        (e)              (e)              (e)              (e)              P=0.251         | 
|COCH-ARM / FISHERS |        P=0.011 *        (e)              (e)              (e)              (e)              P=0.248         | 
|ORDER RESTRICTED   |        P=0.011 *        (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Lung                                                                                                                             | 
|     Cystic Keratinizing Epithelioma                                                                                             | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/53 (0%)        0/54 (0%)        0/53 (0%)        0/52 (0%)        0/53 (0%)        9/52 (17%)      | 
|POLY-3 RATE (b)    |        0/39.55          0/34.61          0/38.75          0/33.71          0/39.00          9/42.72         | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             0.0%             21.1%           | 
|TERMINAL (d)       |        0/25 (0%)        0/21 (0%)        0/23 (0%)        0/19 (0%)        0/22 (0%)        4/21 (19%)      | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              ---              610             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P<0.001 **       (e)              (e)              (e)              (e)              P=0.002 **      | 
|POLY 3             |        P<0.001 **       (e)              (e)              (e)              (e)              P=0.002 **      | 
|POLY 1.5           |        P<0.001 **       (e)              (e)              (e)              (e)              P=0.002 **      | 
|POLY 6             |        P<0.001 **       (e)              (e)              (e)              (e)              P=0.002 **      | 
|LOGISTIC REGRESSION|        P<0.001 **       (e)              (e)              (e)              (e)              P=0.003 **      | 
|COCH-ARM / FISHERS |        P<0.001 **       (e)              (e)              (e)              (e)              P<0.001 **      | 
|ORDER RESTRICTED   |        P<0.001 **       (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  09/30/03                           EXPERIMENT: 96007 TEST: 03                                            Page 6       
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY)       -        TOXIC EQUIVALENCY FACTOR EVALUATION                   
                                         Terminal Sacrifice at 105 weeks                                                            
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Mammary Gland                                                                                                                    | 
|     Adenoma                                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        2/53 (4%)        0/54 (0%)        1/53 (2%)        0/53 (0%)        0/53 (0%)        1/53 (2%)       | 
|POLY-3 RATE (b)    |        2/39.90          0/34.61          1/38.75          0/34.16          0/39.00          1/42.60         | 
|POLY-3 PERCENT (g) |        5.0%             0.0%             2.6%             0.0%             0.0%             2.4%            | 
|TERMINAL (d)       |        1/25 (4%)        0/21 (0%)        1/23 (4%)        0/19 (0%)        0/22 (0%)        1/21 (5%)       | 
|FIRST INCIDENCE    |        631              ---              731 (T)          ---              ---              731 (T)         | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.591N         P=0.305N         P=0.532N         P=0.317N         P=0.260N         P=0.535N        | 
|POLY 3             |        P=0.555N         P=0.270N         P=0.510N         P=0.273N         P=0.242N         P=0.477N        | 
|POLY 1.5           |        P=0.570N         P=0.254N         P=0.511N         P=0.258N         P=0.240N         P=0.479N        | 
|POLY 6             |        P=0.541N         P=0.288N         P=0.512N         P=0.293N         P=0.247N         P=0.488N        | 
|LOGISTIC REGRESSION|        P=0.555N         P=0.263N         P=0.507N         P=0.267N         P=0.240N         P=0.479N        | 
|COCH-ARM / FISHERS |        P=0.595N         P=0.243N         P=0.500N         P=0.248N         P=0.248N         P=0.500N        | 
|ORDER RESTRICTED   |        P=0.110N         (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Mammary Gland                                                                                                                    | 
|     Carcinoma                                                                                                                   | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        4/53 (8%)        8/54 (15%)       4/53 (8%)        2/53 (4%)        2/53 (4%)        0/53 (0%)       | 
|POLY-3 RATE (b)    |        4/40.42          8/37.03          4/39.08          2/35.28          2/39.22          0/42.60         | 
|POLY-3 PERCENT (g) |        9.9%             21.6%            10.2%            5.7%             5.1%             0.0%            | 
|TERMINAL (d)       |        2/25 (8%)        4/21 (19%)       1/23 (4%)        0/19 (0%)        1/22 (5%)        0/21 (0%)       | 
|FIRST INCIDENCE    |        469              241              659              338              673              ---             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.008N**       P=0.127          P=0.616          P=0.439N         P=0.377N         P=0.077N        | 
|POLY 3             |        P=0.004N**       P=0.132          P=0.626          P=0.401N         P=0.350N         P=0.053N        | 
|POLY 1.5           |        P=0.004N**       P=0.155          P=0.624          P=0.374N         P=0.345N         P=0.054N        | 
|POLY 6             |        P=0.004N**       P=0.109          P=0.627          P=0.436N         P=0.360N         P=0.057N        | 
|LOGISTIC REGRESSION|        P=0.006N**       P=0.184          P=0.633          P=0.327N         P=0.340N         P=0.060N        | 
|COCH-ARM / FISHERS |        P=0.006N**       P=0.189          P=0.642N         P=0.339N         P=0.339N         P=0.059N        | 
|ORDER RESTRICTED   |        P=0.005N**       (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  09/30/03                           EXPERIMENT: 96007 TEST: 03                                            Page 7       
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY)       -        TOXIC EQUIVALENCY FACTOR EVALUATION                   
                                         Terminal Sacrifice at 105 weeks                                                            
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Mammary Gland                                                                                                                    | 
|     Carcinoma or Adenoma                                                                                                        | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        6/53 (11%)       8/54 (15%)       5/53 (9%)        2/53 (4%)        2/53 (4%)        1/53 (2%)       | 
|POLY-3 RATE (b)    |        6/40.77          8/37.03          5/39.08          2/35.28          2/39.22          1/42.60         | 
|POLY-3 PERCENT (g) |        14.7%            21.6%            12.8%            5.7%             5.1%             2.4%            | 
|TERMINAL (d)       |        3/25 (12%)       4/21 (19%)       2/23 (9%)        0/19 (0%)        1/22 (5%)        1/21 (5%)       | 
|FIRST INCIDENCE    |        469              241              659              338              673              731 (T)         | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.011N*        P=0.278          P=0.538N         P=0.232N         P=0.168N         P=0.077N        | 
|POLY 3             |        P=0.005N**       P=0.310          P=0.530N         P=0.182N         P=0.143N         P=0.048N*       | 
|POLY 1.5           |        P=0.006N**       P=0.350          P=0.528N         P=0.160N         P=0.139N         P=0.048N*       | 
|POLY 6             |        P=0.005N**       P=0.266          P=0.536N         P=0.214N         P=0.151N         P=0.053N        | 
|LOGISTIC REGRESSION|        P=0.007N**       P=0.385          P=0.515N         P=0.137N         P=0.137N         P=0.051N        | 
|COCH-ARM / FISHERS |        P=0.009N**       P=0.402          P=0.500N         P=0.135N         P=0.135N         P=0.056N        | 
|ORDER RESTRICTED   |        P=0.009N**       (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Mammary Gland                                                                                                                    | 
|     Fibroadenoma                                                                                                                | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        33/53 (62%)      40/54 (74%)      34/53 (64%)      29/53 (55%)      36/53 (68%)      24/53 (45%)     | 
|POLY-3 RATE (b)    |        33/46.50         40/48.95         34/45.82         29/41.25         36/48.31         24/47.04        | 
|POLY-3 PERCENT (g) |        71.0%            81.7%            74.2%            70.3%            74.5%            51.0%           | 
|TERMINAL (d)       |        16/25 (64%)      16/21 (76%)      16/23 (70%)      12/19 (63%)      15/22 (68%)      12/21 (57%)     | 
|FIRST INCIDENCE    |        185              241              236              453              141              396             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.021N*        P=0.048 *        P=0.404          P=0.338          P=0.256          P=0.174N        | 
|POLY 3             |        P<0.001N**       P=0.147          P=0.452          P=0.570N         P=0.435          P=0.031N*       | 
|POLY 1.5           |        P<0.001N**       P=0.129          P=0.418          P=0.468N         P=0.401          P=0.033N*       | 
|POLY 6             |        P=0.002N**       P=0.183          P=0.498          P=0.559          P=0.453          P=0.041N*       | 
|LOGISTIC REGRESSION|        P=0.002N**       P=0.104          P=0.445          P=0.424N         P=0.337          P=0.043N*       | 
|COCH-ARM / FISHERS |        P=0.009N**       P=0.135          P=0.500          P=0.277N         P=0.342          P=0.059N        | 
|ORDER RESTRICTED   |        P=0.002N**       (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  09/30/03                           EXPERIMENT: 96007 TEST: 03                                            Page 8       
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY)       -        TOXIC EQUIVALENCY FACTOR EVALUATION                   
                                         Terminal Sacrifice at 105 weeks                                                            
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Mammary Gland                                                                                                                    | 
|     Fibroma, Fibroadenoma or Adenoma                                                                                            | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        35/53 (66%)      40/54 (74%)      35/53 (66%)      29/53 (55%)      36/53 (68%)      24/53 (45%)     | 
|POLY-3 RATE (b)    |        35/46.86         40/48.95         35/45.82         29/41.25         36/48.31         24/47.04        | 
|POLY-3 PERCENT (g) |        74.7%            81.7%            76.4%            70.3%            74.5%            51.0%           | 
|TERMINAL (d)       |        17/25 (68%)      16/21 (76%)      17/23 (74%)      12/19 (63%)      15/22 (68%)      12/21 (57%)     | 
|FIRST INCIDENCE    |        185              241              236              453              141              396             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.013N*        P=0.079          P=0.454          P=0.435          P=0.352          P=0.109N        | 
|POLY 3             |        P<0.001N**       P=0.269          P=0.522          P=0.407N         P=0.589N         P=0.010N*       | 
|POLY 1.5           |        P<0.001N**       P=0.244          P=0.493          P=0.308N         P=0.572          P=0.011N*       | 
|POLY 6             |        P<0.001N**       P=0.311          P=0.554          P=0.500N         P=0.591N         P=0.015N*       | 
|LOGISTIC REGRESSION|        P<0.001N**       P=0.192          P=0.523          P=0.275N         P=0.495          P=0.016N*       | 
|COCH-ARM / FISHERS |        P=0.004N**       P=0.243          P=0.581N         P=0.160N         P=0.500          P=0.025N*       | 
|ORDER RESTRICTED   |        P<0.001N**       (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Mammary Gland                                                                                                                    | 
|     Fibroma, Fibroadenoma, Carcinoma, or Adenoma                                                                                | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        35/53 (66%)      43/54 (80%)      37/53 (70%)      31/53 (58%)      37/53 (70%)      24/53 (45%)     | 
|POLY-3 RATE (b)    |        35/46.86         43/49.90         37/46.14         31/42.36         37/48.53         24/47.04        | 
|POLY-3 PERCENT (g) |        74.7%            86.2%            80.2%            73.2%            76.2%            51.0%           | 
|TERMINAL (d)       |        17/25 (68%)      17/21 (81%)      17/23 (74%)      12/19 (63%)      15/22 (68%)      12/21 (57%)     | 
|FIRST INCIDENCE    |        185              241              236              338              141              396             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.007N**       P=0.034 *        P=0.344          P=0.318          P=0.303          P=0.109N        | 
|POLY 3             |        P<0.001N**       P=0.107          P=0.343          P=0.533N         P=0.526          P=0.010N*       | 
|POLY 1.5           |        P<0.001N**       P=0.089          P=0.314          P=0.441N         P=0.488          P=0.011N*       | 
|POLY 6             |        P<0.001N**       P=0.135          P=0.389          P=0.606          P=0.546          P=0.015N*       | 
|LOGISTIC REGRESSION|        P<0.001N**       P=0.062          P=0.349          P=0.411N         P=0.412          P=0.016N*       | 
|COCH-ARM / FISHERS |        P<0.001N**       P=0.086          P=0.418          P=0.274N         P=0.418          P=0.025N*       | 
|ORDER RESTRICTED   |        P<0.001N**       (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  09/30/03                           EXPERIMENT: 96007 TEST: 03                                            Page 9       
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY)       -        TOXIC EQUIVALENCY FACTOR EVALUATION                   
                                         Terminal Sacrifice at 105 weeks                                                            
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Oral Cavity (Oral Mucosa, Tongue, Pharynx, Tooth, Gingiva)                                                                       | 
|     Squamous Cell Carcinoma                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        1/53 (2%)        2/54 (4%)        1/53 (2%)        0/53 (0%)        4/53 (8%)        10/53 (19%)     | 
|POLY-3 RATE (b)    |        1/40.42          2/34.91          1/39.25          0/34.16          4/39.40          10/45.45        | 
|POLY-3 PERCENT (g) |        2.5%             5.7%             2.6%             0.0%             10.2%            22.0%           | 
|TERMINAL (d)       |        0/25 (0%)        1/21 (5%)        0/23 (0%)        0/19 (0%)        1/22 (5%)        2/21 (10%)      | 
|FIRST INCIDENCE    |        366              647              578              ---              659              546             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P<0.001 **       P=0.444          P=0.757N         P=0.496N         P=0.166          P=0.009 **      | 
|POLY 3             |        P<0.001 **       P=0.449          P=0.755          P=0.533N         P=0.169          P=0.007 **      | 
|POLY 1.5           |        P<0.001 **       P=0.471          P=0.753          P=0.520N         P=0.173          P=0.006 **      | 
|POLY 6             |        P<0.001 **       P=0.428          P=0.756          P=0.549N         P=0.165          P=0.007 **      | 
|LOGISTIC REGRESSION|        P<0.001 **       P=0.527          P=0.725N         P=0.436N         P=0.180          P=0.002 **      | 
|COCH-ARM / FISHERS |        P<0.001 **       P=0.507          P=0.752N         P=0.500N         P=0.181          P=0.004 **      | 
|ORDER RESTRICTED   |        P<0.001 **       (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Oral Cavity (Oral Mucosa, Tongue, Pharynx, Tooth, Gingiva)                                                                       | 
|     Squamous Cell Carcinoma, Papilloma Squamous, or Papilloma                                                                   | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        1/53 (2%)        2/54 (4%)        1/53 (2%)        0/53 (0%)        4/53 (8%)        10/53 (19%)     | 
|POLY-3 RATE (b)    |        1/40.42          2/34.91          1/39.25          0/34.16          4/39.40          10/45.45        | 
|POLY-3 PERCENT (g) |        2.5%             5.7%             2.6%             0.0%             10.2%            22.0%           | 
|TERMINAL (d)       |        0/25 (0%)        1/21 (5%)        0/23 (0%)        0/19 (0%)        1/22 (5%)        2/21 (10%)      | 
|FIRST INCIDENCE    |        366              647              578              ---              659              546             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P<0.001 **       P=0.444          P=0.757N         P=0.496N         P=0.166          P=0.009 **      | 
|POLY 3             |        P<0.001 **       P=0.449          P=0.755          P=0.533N         P=0.169          P=0.007 **      | 
|POLY 1.5           |        P<0.001 **       P=0.471          P=0.753          P=0.520N         P=0.173          P=0.006 **      | 
|POLY 6             |        P<0.001 **       P=0.428          P=0.756          P=0.549N         P=0.165          P=0.007 **      | 
|LOGISTIC REGRESSION|        P<0.001 **       P=0.527          P=0.725N         P=0.436N         P=0.180          P=0.002 **      | 
|COCH-ARM / FISHERS |        P<0.001 **       P=0.507          P=0.752N         P=0.500N         P=0.181          P=0.004 **      | 
|ORDER RESTRICTED   |        P<0.001 **       (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  09/30/03                           EXPERIMENT: 96007 TEST: 03                                            Page 10      
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY)       -        TOXIC EQUIVALENCY FACTOR EVALUATION                   
                                         Terminal Sacrifice at 105 weeks                                                            
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Oral Mucosa                                                                                                                      | 
|     Squamous Cell Carcinoma                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        1/53 (2%)        2/54 (4%)        1/53 (2%)        0/53 (0%)        4/53 (8%)        10/53 (19%)     | 
|POLY-3 RATE (b)    |        1/40.42          2/34.91          1/39.25          0/34.16          4/39.40          10/45.45        | 
|POLY-3 PERCENT (g) |        2.5%             5.7%             2.6%             0.0%             10.2%            22.0%           | 
|TERMINAL (d)       |        0/25 (0%)        1/21 (5%)        0/23 (0%)        0/19 (0%)        1/22 (5%)        2/21 (10%)      | 
|FIRST INCIDENCE    |        366              647              578              ---              659              546             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P<0.001 **       P=0.444          P=0.757N         P=0.496N         P=0.166          P=0.009 **      | 
|POLY 3             |        P<0.001 **       P=0.449          P=0.755          P=0.533N         P=0.169          P=0.007 **      | 
|POLY 1.5           |        P<0.001 **       P=0.471          P=0.753          P=0.520N         P=0.173          P=0.006 **      | 
|POLY 6             |        P<0.001 **       P=0.428          P=0.756          P=0.549N         P=0.165          P=0.007 **      | 
|LOGISTIC REGRESSION|        P<0.001 **       P=0.527          P=0.725N         P=0.436N         P=0.180          P=0.002 **      | 
|COCH-ARM / FISHERS |        P<0.001 **       P=0.507          P=0.752N         P=0.500N         P=0.181          P=0.004 **      | 
|ORDER RESTRICTED   |        P<0.001 **       (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Pancreas                                                                                                                         | 
|     Carcinoma                                                                                                                   | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/51 (0%)        0/54 (0%)        0/52 (0%)        0/53 (0%)        0/52 (0%)        2/51 (4%)       | 
|POLY-3 RATE (b)    |        0/38.86          0/34.61          0/38.64          0/34.16          0/38.45          2/41.18         | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             0.0%             4.9%            | 
|TERMINAL (d)       |        0/25 (0%)        0/21 (0%)        0/23 (0%)        0/19 (0%)        0/22 (0%)        1/21 (5%)       | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              ---              641             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.014 *        (e)              (e)              (e)              (e)              P=0.223         | 
|POLY 3             |        P=0.011 *        (e)              (e)              (e)              (e)              P=0.250         | 
|POLY 1.5           |        P=0.011 *        (e)              (e)              (e)              (e)              P=0.249         | 
|POLY 6             |        P=0.011 *        (e)              (e)              (e)              (e)              P=0.244         | 
|LOGISTIC REGRESSION|        P=0.014 *        (e)              (e)              (e)              (e)              P=0.247         | 
|COCH-ARM / FISHERS |        P=0.010 *        (e)              (e)              (e)              (e)              P=0.248         | 
|ORDER RESTRICTED   |        P=0.011 *        (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  09/30/03                           EXPERIMENT: 96007 TEST: 03                                            Page 11      
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY)       -        TOXIC EQUIVALENCY FACTOR EVALUATION                   
                                         Terminal Sacrifice at 105 weeks                                                            
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Pancreas                                                                                                                         | 
|     Carcinoma or Adenoma                                                                                                        | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/51 (0%)        0/54 (0%)        0/52 (0%)        0/53 (0%)        0/52 (0%)        3/51 (6%)       | 
|POLY-3 RATE (b)    |        0/38.86          0/34.61          0/38.64          0/34.16          0/38.45          3/41.18         | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             0.0%             7.3%            | 
|TERMINAL (d)       |        0/25 (0%)        0/21 (0%)        0/23 (0%)        0/19 (0%)        0/22 (0%)        2/21 (10%)      | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              ---              641             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P<0.001 **       (e)              (e)              (e)              (e)              P=0.104         | 
|POLY 3             |        P<0.001 **       (e)              (e)              (e)              (e)              P=0.129         | 
|POLY 1.5           |        P<0.001 **       (e)              (e)              (e)              (e)              P=0.128         | 
|POLY 6             |        P<0.001 **       (e)              (e)              (e)              (e)              P=0.123         | 
|LOGISTIC REGRESSION|        P=0.002 **       (e)              (e)              (e)              (e)              P=0.125         | 
|COCH-ARM / FISHERS |        P<0.001 **       (e)              (e)              (e)              (e)              P=0.121         | 
|ORDER RESTRICTED   |        P=0.002 **       (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Pituitary Gland: Pars Distalis or Unspecified Site                                                                               | 
|     Adenoma                                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        25/53 (47%)      20/54 (37%)      26/52 (50%)      15/53 (28%)      20/53 (38%)      11/52 (21%)     | 
|POLY-3 RATE (b)    |        25/42.82         20/36.20         26/40.49         15/36.38         20/42.25         11/44.01        | 
|POLY-3 PERCENT (g) |        58.4%            55.3%            64.2%            41.2%            47.3%            25.0%           | 
|TERMINAL (d)       |        15/25 (60%)      16/21 (76%)      15/23 (65%)      9/19 (47%)       10/22 (46%)      4/21 (19%)      | 
|FIRST INCIDENCE    |        474              604              550              545              444              604             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.004N**       P=0.542N         P=0.397          P=0.253N         P=0.356N         P=0.016N*       | 
|POLY 3             |        P<0.001N**       P=0.478N         P=0.369          P=0.087N         P=0.202N         P<0.001N**      | 
|POLY 1.5           |        P<0.001N**       P=0.334N         P=0.372          P=0.056N         P=0.203N         P<0.001N**      | 
|POLY 6             |        P<0.001N**       P=0.545          P=0.363          P=0.146N         P=0.212N         P<0.001N**      | 
|LOGISTIC REGRESSION|        P<0.001N**       P=0.503N         P=0.420          P=0.102N         P=0.216N         P<0.001N**      | 
|COCH-ARM / FISHERS |        P=0.003N**       P=0.193N         P=0.462          P=0.035N*        P=0.216N         P=0.004N**      | 
|ORDER RESTRICTED   |        P<0.001N**       (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  09/30/03                           EXPERIMENT: 96007 TEST: 03                                            Page 12      
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY)       -        TOXIC EQUIVALENCY FACTOR EVALUATION                   
                                         Terminal Sacrifice at 105 weeks                                                            
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Pituitary Gland: Pars Intermedia                                                                                                 | 
|     Adenoma                                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        2/53 (4%)        0/54 (0%)        0/52 (0%)        0/53 (0%)        0/53 (0%)        0/52 (0%)       | 
|POLY-3 RATE (b)    |        2/39.60          0/34.61          0/38.01          0/34.16          0/39.00          0/42.44         | 
|POLY-3 PERCENT (g) |        5.1%             0.0%             0.0%             0.0%             0.0%             0.0%            | 
|TERMINAL (d)       |        1/25 (4%)        0/21 (0%)        0/23 (0%)        0/19 (0%)        0/22 (0%)        0/21 (0%)       | 
|FIRST INCIDENCE    |        717              ---              ---              ---              ---              ---             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.259N         P=0.277N         P=0.245N         P=0.311N         P=0.272N         P=0.268N        | 
|POLY 3             |        P=0.226N         P=0.268N         P=0.246N         P=0.271N         P=0.240N         P=0.222N        | 
|POLY 1.5           |        P=0.235N         P=0.253N         P=0.248N         P=0.257N         P=0.239N         P=0.225N        | 
|POLY 6             |        P=0.216N         P=0.284N         P=0.244N         P=0.290N         P=0.244N         P=0.226N        | 
|LOGISTIC REGRESSION|        P=0.243N         P=0.286N         P=0.242N         P=0.303N         P=0.254N         P=0.246N        | 
|COCH-ARM / FISHERS |        P=0.250N         P=0.243N         P=0.252N         P=0.248N         P=0.248N         P=0.252N        | 
|ORDER RESTRICTED   |        P=0.007N**       (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Skin                                                                                                                             | 
|     Fibroma                                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        1/53 (2%)        0/54 (0%)        2/53 (4%)        0/53 (0%)        0/53 (0%)        1/53 (2%)       | 
|POLY-3 RATE (b)    |        1/40.13          0/34.61          2/39.56          0/34.16          0/39.00          1/42.65         | 
|POLY-3 PERCENT (g) |        2.5%             0.0%             5.1%             0.0%             0.0%             2.3%            | 
|TERMINAL (d)       |        0/25 (0%)        0/21 (0%)        0/23 (0%)        0/19 (0%)        0/22 (0%)        0/21 (0%)       | 
|FIRST INCIDENCE    |        548              ---              578              ---              ---              717             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.605N         P=0.505N         P=0.509          P=0.515N         P=0.490N         P=0.747N        | 
|POLY 3             |        P=0.612N         P=0.529N         P=0.495          P=0.532N         P=0.506N         P=0.747N        | 
|POLY 1.5           |        P=0.628N         P=0.516N         P=0.491          P=0.519N         P=0.503N         P=0.748N        | 
|POLY 6             |        P=0.601N         P=0.544N         P=0.499          P=0.548N         P=0.511N         P=0.755N        | 
|LOGISTIC REGRESSION|        P=0.653          P=0.475N         P=0.511          P=0.479N         P=0.497N         P=0.753         | 
|COCH-ARM / FISHERS |        P=0.650N         P=0.495N         P=0.500          P=0.500N         P=0.500N         P=0.752N        | 
|ORDER RESTRICTED   |        P=0.480N         (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  09/30/03                           EXPERIMENT: 96007 TEST: 03                                            Page 13      
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY)       -        TOXIC EQUIVALENCY FACTOR EVALUATION                   
                                         Terminal Sacrifice at 105 weeks                                                            
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Skin                                                                                                                             | 
|     Fibroma, Fibrosarcoma, Sarcoma, Myxoma, Myxosarcoma,                                                                        | 
|     or Fibrous Histiocytoma                                                                                                     | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        1/53 (2%)        0/54 (0%)        3/53 (6%)        1/53 (2%)        0/53 (0%)        1/53 (2%)       | 
|POLY-3 RATE (b)    |        1/40.13          0/34.61          3/39.97          1/34.16          0/39.00          1/42.65         | 
|POLY-3 PERCENT (g) |        2.5%             0.0%             7.5%             2.9%             0.0%             2.3%            | 
|TERMINAL (d)       |        0/25 (0%)        0/21 (0%)        0/23 (0%)        1/19 (5%)        0/22 (0%)        0/21 (0%)       | 
|FIRST INCIDENCE    |        548              ---              578              731 (T)          ---              717             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.451N         P=0.505N         P=0.313          P=0.721          P=0.490N         P=0.747N        | 
|POLY 3             |        P=0.439N         P=0.529N         P=0.303          P=0.724          P=0.506N         P=0.747N        | 
|POLY 1.5           |        P=0.458N         P=0.516N         P=0.298          P=0.740          P=0.503N         P=0.748N        | 
|POLY 6             |        P=0.430N         P=0.544N         P=0.309          P=0.704          P=0.511N         P=0.755N        | 
|LOGISTIC REGRESSION|        P=0.482N         P=0.475N         P=0.314          P=0.755          P=0.497N         P=0.753         | 
|COCH-ARM / FISHERS |        P=0.493N         P=0.495N         P=0.309          P=0.752N         P=0.500N         P=0.752N        | 
|ORDER RESTRICTED   |        P=0.459N         (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Skin                                                                                                                             | 
|     Schwannoma Malignant                                                                                                        | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        1/53 (2%)        0/54 (0%)        0/53 (0%)        2/53 (4%)        0/53 (0%)        1/53 (2%)       | 
|POLY-3 RATE (b)    |        1/39.67          0/34.61          0/38.75          2/35.78          0/39.00          1/43.05         | 
|POLY-3 PERCENT (g) |        2.5%             0.0%             0.0%             5.6%             0.0%             2.3%            | 
|TERMINAL (d)       |        0/25 (0%)        0/21 (0%)        0/23 (0%)        0/19 (0%)        0/22 (0%)        0/21 (0%)       | 
|FIRST INCIDENCE    |        701              ---              ---              380              ---              599             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.559          P=0.539N         P=0.500N         P=0.459          P=0.515N         P=0.747N        | 
|POLY 3             |        P=0.576          P=0.527N         P=0.505N         P=0.464          P=0.503N         P=0.743N        | 
|POLY 1.5           |        P=0.563          P=0.515N         P=0.506N         P=0.479          P=0.502N         P=0.745N        | 
|POLY 6             |        P=0.577          P=0.541N         P=0.505N         P=0.443          P=0.507N         P=0.748N        | 
|LOGISTIC REGRESSION|        P=0.441          P=0.536N         P=0.504N         P=0.552          P=0.505N         P=0.763         | 
|COCH-ARM / FISHERS |        P=0.519          P=0.495N         P=0.500N         P=0.500          P=0.500N         P=0.752N        | 
|ORDER RESTRICTED   |        P=0.501          (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  09/30/03                           EXPERIMENT: 96007 TEST: 03                                            Page 14      
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY)       -        TOXIC EQUIVALENCY FACTOR EVALUATION                   
                                         Terminal Sacrifice at 105 weeks                                                            
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Stomach, Forestomach                                                                                                             | 
|     Squamous Cell Carcinoma or Papilloma Squamous                                                                               | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        1/53 (2%)        0/54 (0%)        0/53 (0%)        0/53 (0%)        2/53 (4%)        1/53 (2%)       | 
|POLY-3 RATE (b)    |        1/39.86          0/34.61          0/38.75          0/34.16          2/39.21          1/42.60         | 
|POLY-3 PERCENT (g) |        2.5%             0.0%             0.0%             0.0%             5.1%             2.4%            | 
|TERMINAL (d)       |        0/25 (0%)        0/21 (0%)        0/23 (0%)        0/19 (0%)        0/22 (0%)        1/21 (5%)       | 
|FIRST INCIDENCE    |        646              ---              ---              ---              701              731 (T)         | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.274          P=0.570N         P=0.523N         P=0.586N         P=0.472          P=0.738         | 
|POLY 3             |        P=0.326          P=0.528N         P=0.506N         P=0.531N         P=0.494          P=0.746N        | 
|POLY 1.5           |        P=0.310          P=0.515N         P=0.506N         P=0.518N         P=0.497          P=0.747N        | 
|POLY 6             |        P=0.328          P=0.542N         P=0.506N         P=0.547N         P=0.488          P=0.754N        | 
|LOGISTIC REGRESSION|        P=0.299          P=0.508N         P=0.502N         P=0.511N         P=0.495          P=0.749N        | 
|COCH-ARM / FISHERS |        P=0.259          P=0.495N         P=0.500N         P=0.500N         P=0.500          P=0.752N        | 
|ORDER RESTRICTED   |        P=0.249          (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Thyroid Gland: C-Cell                                                                                                            | 
|     Adenoma                                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        20/52 (38%)      15/54 (28%)      17/53 (32%)      16/51 (31%)      13/53 (25%)      11/52 (21%)     | 
|POLY-3 RATE (b)    |        20/42.85         15/37.10         17/39.42         16/37.06         13/41.12         11/43.05        | 
|POLY-3 PERCENT (g) |        46.7%            40.4%            43.1%            43.2%            31.6%            25.6%           | 
|TERMINAL (d)       |        10/25 (40%)      10/21 (48%)      13/23 (57%)      8/19 (42%)       8/22 (36%)       6/21 (29%)      | 
|FIRST INCIDENCE    |        474              462              626              338              486              638             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.048N*        P=0.422N         P=0.430N         P=0.551          P=0.180N         P=0.091N        | 
|POLY 3             |        P=0.010N*        P=0.366N         P=0.459N         P=0.464N         P=0.111N         P=0.030N*       | 
|POLY 1.5           |        P=0.015N*        P=0.268N         P=0.413N         P=0.382N         P=0.099N         P=0.028N*       | 
|POLY 6             |        P=0.010N*        P=0.499N         P=0.533N         P=0.579N         P=0.139N         P=0.043N*       | 
|LOGISTIC REGRESSION|        P=0.014N*        P=0.286N         P=0.338N         P=0.385N         P=0.093N         P=0.028N*       | 
|COCH-ARM / FISHERS |        P=0.047N*        P=0.168N         P=0.316N         P=0.292N         P=0.092N         P=0.043N*       | 
|ORDER RESTRICTED   |        P=0.021N*        (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  09/30/03                           EXPERIMENT: 96007 TEST: 03                                            Page 15      
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY)       -        TOXIC EQUIVALENCY FACTOR EVALUATION                   
                                         Terminal Sacrifice at 105 weeks                                                            
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Thyroid Gland: C-Cell                                                                                                            | 
|     Carcinoma                                                                                                                   | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        1/52 (2%)        1/54 (2%)        0/53 (0%)        0/51 (0%)        2/53 (4%)        0/52 (0%)       | 
|POLY-3 RATE (b)    |        1/38.90          1/35.04          0/38.75          0/33.58          2/39.00          0/41.66         | 
|POLY-3 PERCENT (g) |        2.6%             2.9%             0.0%             0.0%             5.1%             0.0%            | 
|TERMINAL (d)       |        1/25 (4%)        0/21 (0%)        0/23 (0%)        0/19 (0%)        2/22 (9%)        0/21 (0%)       | 
|FIRST INCIDENCE    |        731 (T)          604              ---              ---              731 (T)          ---             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.506N         P=0.712          P=0.517N         P=0.555N         P=0.455          P=0.535N        | 
|POLY 3             |        P=0.468N         P=0.738          P=0.501N         P=0.529N         P=0.501          P=0.486N        | 
|POLY 1.5           |        P=0.475N         P=0.750          P=0.502N         P=0.519N         P=0.504          P=0.487N        | 
|POLY 6             |        P=0.472N         P=0.724          P=0.501N         P=0.543N         P=0.493          P=0.492N        | 
|LOGISTIC REGRESSION|        P=0.474N         P=0.749          (e)              (e)              P=0.455          (e)             | 
|COCH-ARM / FISHERS |        P=0.511N         P=0.743N         P=0.495N         P=0.505N         P=0.507          P=0.500N        | 
|ORDER RESTRICTED   |        P=0.306N         (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Thyroid Gland: C-Cell                                                                                                            | 
|     Carcinoma or Adenoma                                                                                                        | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |                                                                                                             | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        21/52 (40%)      15/54 (28%)      17/53 (32%)      16/51 (31%)      14/53 (26%)      11/52 (21%)     | 
|POLY-3 RATE (b)    |        21/42.85         15/37.10         17/39.42         16/37.06         14/41.12         11/43.05        | 
|POLY-3 PERCENT (g) |        49.0%            40.4%            43.1%            43.2%            34.0%            25.6%           | 
|TERMINAL (d)       |        11/25 (44%)      10/21 (48%)      13/23 (57%)      8/19 (42%)       9/22 (41%)       6/21 (29%)      | 
|FIRST INCIDENCE    |        474              462              626              338              486              638             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.044N*        P=0.354N         P=0.358N         P=0.534N         P=0.188N         P=0.066N        | 
|POLY 3             |        P=0.008N**       P=0.288N         P=0.374N         P=0.380N         P=0.115N         P=0.017N*       | 
|POLY 1.5           |        P=0.013N*        P=0.202N         P=0.333N         P=0.304N         P=0.101N         P=0.016N*       | 
|POLY 6             |        P=0.008N**       P=0.415N         P=0.446N         P=0.495N         P=0.145N         P=0.025N*       | 
|LOGISTIC REGRESSION|        P=0.012N*        P=0.225N         P=0.264N         P=0.316N         P=0.095N         P=0.016N*       | 
|COCH-ARM / FISHERS |        P=0.043N*        P=0.122N         P=0.247N         P=0.227N         P=0.095N         P=0.027N*       | 
|ORDER RESTRICTED   |        P=0.011N*        (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  09/30/03                           EXPERIMENT: 96007 TEST: 03                                            Page 16      
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY)       -        TOXIC EQUIVALENCY FACTOR EVALUATION                   
                                         Terminal Sacrifice at 105 weeks                                                            
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Uterus                                                                                                                           | 
|     Carcinoma                                                                                                                   | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/53 (0%)        2/54 (4%)        0/53 (0%)        1/53 (2%)        2/53 (4%)        1/53 (2%)       | 
|POLY-3 RATE (b)    |        0/39.55          2/34.61          0/38.75          1/34.16          2/39.00          1/42.66         | 
|POLY-3 PERCENT (g) |        0.0%             5.8%             0.0%             2.9%             5.1%             2.3%            | 
|TERMINAL (d)       |        0/25 (0%)        2/21 (10%)       0/23 (0%)        1/19 (5%)        2/22 (9%)        0/21 (0%)       | 
|FIRST INCIDENCE    |        ---              731 (T)          ---              731 (T)          731 (T)          716             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.421          P=0.200          (e)              P=0.445          P=0.210          P=0.492         | 
|POLY 3             |        P=0.489          P=0.208          (e)              P=0.471          P=0.233          P=0.515         | 
|POLY 1.5           |        P=0.485          P=0.221          (e)              P=0.483          P=0.235          P=0.513         | 
|POLY 6             |        P=0.476          P=0.195          (e)              P=0.456          P=0.229          P=0.511         | 
|LOGISTIC REGRESSION|        P=0.443          P=0.200          (e)              P=0.445          P=0.210          P=0.501         | 
|COCH-ARM / FISHERS |        P=0.441          P=0.252          (e)              P=0.500          P=0.248          P=0.500         | 
|ORDER RESTRICTED   |        P=0.246          (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Uterus                                                                                                                           | 
|     Polyp Stromal                                                                                                               | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        11/53 (21%)      7/54 (13%)       4/53 (8%)        11/53 (21%)      10/53 (19%)      8/53 (15%)      | 
|POLY-3 RATE (b)    |        11/40.11         7/35.74          4/39.04          11/36.29         10/40.43         8/44.05         | 
|POLY-3 PERCENT (g) |        27.4%            19.6%            10.3%            30.3%            24.7%            18.2%           | 
|TERMINAL (d)       |        8/25 (32%)       5/21 (24%)       2/23 (9%)        6/19 (32%)       5/22 (23%)       3/21 (14%)      | 
|FIRST INCIDENCE    |        645              526              659              557              590              598             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.531          P=0.361N         P=0.064N         P=0.314          P=0.589          P=0.400N        | 
|POLY 3             |        P=0.404N         P=0.296N         P=0.045N*        P=0.490          P=0.492N         P=0.223N        | 
|POLY 1.5           |        P=0.452N         P=0.257N         P=0.048N*        P=0.531          P=0.496N         P=0.240N        | 
|POLY 6             |        P=0.386N         P=0.342N         P=0.043N*        P=0.445          P=0.491N         P=0.225N        | 
|LOGISTIC REGRESSION|        P=0.439N         P=0.359N         P=0.045N*        P=0.395          P=0.527N         P=0.253N        | 
|COCH-ARM / FISHERS |        P=0.497          P=0.207N         P=0.046N*        P=0.594N         P=0.500N         P=0.307N        | 
|ORDER RESTRICTED   |        P=0.245N         (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  09/30/03                           EXPERIMENT: 96007 TEST: 03                                            Page 17      
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY)       -        TOXIC EQUIVALENCY FACTOR EVALUATION                   
                                         Terminal Sacrifice at 105 weeks                                                            
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|Uterus                                                                                                                           | 
|     Squamous Cell Carcinoma                                                                                                     | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/53 (0%)        0/54 (0%)        0/53 (0%)        0/53 (0%)        5/53 (9%)        0/53 (0%)       | 
|POLY-3 RATE (b)    |        0/39.55          0/34.61          0/38.75          0/34.16          5/40.55          0/42.60         | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             12.3%            0.0%            | 
|TERMINAL (d)       |        0/25 (0%)        0/21 (0%)        0/23 (0%)        0/19 (0%)        0/22 (0%)        0/21 (0%)       | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              589              ---             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.300          (e)              (e)              (e)              P=0.035 *        (e)             | 
|POLY 3             |        P=0.337          (e)              (e)              (e)              P=0.032 *        (e)             | 
|POLY 1.5           |        P=0.318          (e)              (e)              (e)              P=0.031 *        (e)             | 
|POLY 6             |        P=0.328          (e)              (e)              (e)              P=0.033 *        (e)             | 
|LOGISTIC REGRESSION|        P=0.259          (e)              (e)              (e)              P=0.033 *        (e)             | 
|COCH-ARM / FISHERS |        P=0.247          (e)              (e)              (e)              P=0.028 *        (e)             | 
|ORDER RESTRICTED   |        P=0.033 *        (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|All Organs                                                                                                                       | 
|     Hemangiosarcoma                                                                                                             | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/53 (0%)        0/54 (0%)        0/53 (0%)        0/53 (0%)        2/53 (4%)        0/53 (0%)       | 
|POLY-3 RATE (b)    |        0/39.55          0/34.61          0/38.75          0/34.16          2/39.00          0/42.60         | 
|POLY-3 PERCENT (g) |        0.0%             0.0%             0.0%             0.0%             5.1%             0.0%            | 
|TERMINAL (d)       |        0/25 (0%)        0/21 (0%)        0/23 (0%)        0/19 (0%)        2/22 (9%)        0/21 (0%)       | 
|FIRST INCIDENCE    |        ---              ---              ---              ---              731 (T)          ---             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.446          (e)              (e)              (e)              P=0.210          (e)             | 
|POLY 3             |        P=0.544          (e)              (e)              (e)              P=0.233          (e)             | 
|POLY 1.5           |        P=0.527          (e)              (e)              (e)              P=0.235          (e)             | 
|POLY 6             |        P=0.542          (e)              (e)              (e)              P=0.229          (e)             | 
|LOGISTIC REGRESSION|        (e)              (e)              (e)              (e)              P=0.210          (e)             | 
|COCH-ARM / FISHERS |        P=0.461          (e)              (e)              (e)              P=0.248          (e)             | 
|ORDER RESTRICTED   |        P=0.183          (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  09/30/03                           EXPERIMENT: 96007 TEST: 03                                            Page 18      
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY)       -        TOXIC EQUIVALENCY FACTOR EVALUATION                   
                                         Terminal Sacrifice at 105 weeks                                                            
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|All Organs                                                                                                                       | 
|     Malignant Lymphoma: Histiocytic, Lymphocytic, Mixed,                                                                        | 
|     NOS, or Undifferentiated Cell Type                                                                                          | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        0/53 (0%)        1/54 (2%)        1/53 (2%)        0/53 (0%)        1/53 (2%)        2/53 (4%)       | 
|POLY-3 RATE (b)    |        0/39.55          1/35.31          1/39.12          0/34.16          1/39.64          2/42.60         | 
|POLY-3 PERCENT (g) |        0.0%             2.8%             2.6%             0.0%             2.5%             4.7%            | 
|TERMINAL (d)       |        0/25 (0%)        0/21 (0%)        0/23 (0%)        0/19 (0%)        0/22 (0%)        2/21 (10%)      | 
|FIRST INCIDENCE    |        ---              490              626              ---              518              731 (T)         | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.170          P=0.491          P=0.484          (e)              P=0.505          P=0.200         | 
|POLY 3             |        P=0.172          P=0.477          P=0.498          (e)              P=0.500          P=0.254         | 
|POLY 1.5           |        P=0.166          P=0.488          P=0.496          (e)              P=0.500          P=0.252         | 
|POLY 6             |        P=0.169          P=0.467          P=0.500          (e)              P=0.499          P=0.247         | 
|LOGISTIC REGRESSION|        P=0.138          P=0.536          P=0.500          (e)              P=0.504          P=0.200         | 
|COCH-ARM / FISHERS |        P=0.145          P=0.505          P=0.500          (e)              P=0.500          P=0.248         | 
|ORDER RESTRICTED   |        P=0.107          (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|All Organs                                                                                                                       | 
|     Benign Tumors                                                                                                               | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        45/53 (85%)      49/54 (91%)      45/53 (85%)      40/53 (75%)      46/53 (87%)      42/53 (79%)     | 
|POLY-3 RATE (b)    |        45/48.82         49/50.46         45/47.09         40/44.36         46/49.52         42/49.59        | 
|POLY-3 PERCENT (g) |        92.2%            97.1%            95.6%            90.2%            92.9%            84.7%           | 
|TERMINAL (d)       |        23/25 (92%)      21/21 (100%)     22/23 (96%)      17/19 (90%)      21/22 (96%)      18/21 (86%)     | 
|FIRST INCIDENCE    |        185              241              236              338              141              396             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.198N         P=0.069          P=0.432          P=0.268          P=0.312          P=0.555         | 
|POLY 3             |        P=0.010N*        P=0.232          P=0.383          P=0.511N         P=0.610          P=0.173N        | 
|POLY 1.5           |        P=0.017N*        P=0.211          P=0.368          P=0.349N         P=0.575          P=0.182N        | 
|POLY 6             |        P=0.019N*        P=0.301          P=0.440          P=0.657N         P=0.619          P=0.217N        | 
|LOGISTIC REGRESSION|        P=0.007N**       P=0.129          P=0.451          P=0.309N         P=0.487          P=0.125N        | 
|COCH-ARM / FISHERS |        P=0.178N         P=0.266          P=0.607N         P=0.165N         P=0.500          P=0.307N        | 
|ORDER RESTRICTED   |        P=0.018N*        (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
                                                                                                                                   
       Date:  09/30/03                           EXPERIMENT: 96007 TEST: 03                                            Page 19      
Statistical Analysis of Primary Tumors in Rats(SPRAGUE-DAWLEY)       -        TOXIC EQUIVALENCY FACTOR EVALUATION                   
                                         Terminal Sacrifice at 105 weeks                                                            
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|All Organs                                                                                                                       | 
|     Malignant Tumors                                                                                                            | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        13/53 (25%)      19/54 (35%)      13/53 (25%)      11/53 (21%)      24/53 (45%)      34/53 (64%)     | 
|POLY-3 RATE (b)    |        13/43.94         19/41.93         13/42.97         11/38.84         24/42.50         34/48.63        | 
|POLY-3 PERCENT (g) |        29.6%            45.3%            30.3%            28.3%            56.5%            69.9%           | 
|TERMINAL (d)       |        4/25 (16%)       7/21 (33%)       3/23 (13%)       3/19 (16%)       12/22 (55%)      14/21 (67%)     | 
|FIRST INCIDENCE    |        169              200              240              338              518              546             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P<0.001 **       P=0.090          P=0.533          P=0.549          P=0.022 *        P<0.001 **      | 
|POLY 3             |        P<0.001 **       P=0.093          P=0.566          P=0.547N         P=0.008 **       P<0.001 **      | 
|POLY 1.5           |        P<0.001 **       P=0.121          P=0.554          P=0.493N         P=0.010 *        P<0.001 **      | 
|POLY 6             |        P<0.001 **       P=0.067          P=0.579          P=0.581          P=0.006 **       P<0.001 **      | 
|LOGISTIC REGRESSION|        P<0.001 **       P=0.211          P=0.572N         P=0.355N         P=0.019 *        P<0.001 **      | 
|COCH-ARM / FISHERS |        P<0.001 **       P=0.160          P=0.589N         P=0.408N         P=0.020 *        P<0.001 **      | 
|ORDER RESTRICTED   |        P<0.001 **       (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
|                   |                                                                                                             | 
|                   |                                                      Females                                                | 
|Dose               |        0 NG/KG          3 NG/KG          10 NG/KG         22 NG/KG         46 NG/KG         100             | 
|                   |                                                                                             NG/KG           | 
|=================================================================================================================================| 
|                                                                                                                                 | 
|All Organs                                                                                                                       | 
|     Malignant and Benign Tumors                                                                                                 | 
|                                                                                                                                 | 
|                                                                                                                                 | 
|---------------------------------------------------------------------------------------------------------------------------------| 
|TUMOR RATES        |        #                #                #                #                #                #               | 
|-----------        |                                                                                                             | 
|OVERALL (a)        |        47/53 (89%)      54/54 (100%)     48/53 (91%)      44/53 (83%)      50/53 (94%)      50/53 (94%)     | 
|POLY-3 RATE (b)    |        47/50.68         54/54.00         48/49.12         44/46.61         50/51.10         50/51.78        | 
|POLY-3 PERCENT (g) |        92.7%            100.0%           97.7%            94.4%            97.9%            96.6%           | 
|TERMINAL (d)       |        23/25 (92%)      21/21 (100%)     22/23 (96%)      18/19 (95%)      21/22 (96%)      20/21 (95%)     | 
|FIRST INCIDENCE    |        169              200              236              338              141              396             | 
|-------------------|                                                                                                             | 
|STATISTICAL TESTS  |                                                                                                             | 
|-------------------|                                                                                                             | 
|LIFE TABLE         |        P=0.436N         P=0.037 *        P=0.376          P=0.184          P=0.233          P=0.256         | 
|POLY 3             |        P=0.560          P=0.046 *        P=0.223          P=0.535          P=0.205          P=0.317         | 
|POLY 1.5           |        P=0.526          P=0.027 *        P=0.191          P=0.650          P=0.168          P=0.286         | 
|POLY 6             |        P=0.571          P=0.088          P=0.314          P=0.464          P=0.298          P=0.360         | 
|LOGISTIC REGRESSION|        P=0.387N         P=0.014 *        P=0.358          P=0.423N         P=0.230          P=0.346         | 
|COCH-ARM / FISHERS |        P=0.342          P=0.013 *        P=0.500          P=0.289N         P=0.244          P=0.244         | 
|ORDER RESTRICTED   |        P=0.109          (e)              (e)              (e)              (e)              (e)             | 
|=================================================================================================================================| 
(a)  Number of tumor-bearing animals /  number of animals examined at site.                                                         
(b)  Number of tumor-bearing animals / Poly-3 number                                                                                
                                                                                                                                   
(d)  Observed incidence at terminal kill.                                                                                           
(f)  Beneath the control incidence are the P-values associated with the trend                                                       
test.  Beneath the dosed group incidence are the P-values corresponding to                                                          
pairwise comparisons between the controls and that dosed group.  The life                                                           
table analysis regards tumors in animals dying prior to  terminal kill as                                                           
 being (directly or indirectly) the cause of death.                                                                                 
Logistic regression is an alternative                                                                                               
 method for analyzing the incidence of non-fatal tumors. The Cochran-Armitage                                                       
and Fishers exact tests compare directly the overall incidence rates                                                                
For all tests a negative trend is indicated by N                                                                                    
(e)  Value of Statistic cannot be computed.                                                                                         
(g)  Poly-3 adjusted lifetime tumor incidence.                                                                                      
(I)  Interim sacrifice                                                                                                              
(T)  Terminal sacrifice                                                                                                             
#   Tumor rates based on number of animals necropsied.                                                                              
*   To the right of any statistical result, indicates significance at (P<=0.05).                                                    
**  To the right of any statistical result, indicates significance at (P<=0.01).                                                    
NTP is located at the National Institute of Environmental Health Sciences, part of the National Institutes of Health.